Dexcom Inc
SWB:DC4
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
D
|
Dexcom Inc
SWB:DC4
|
US |
|
Applied DNA Sciences Inc
NASDAQ:BNBX
|
US |
|
Sanrio Co Ltd
F:SJ8
|
JP |
|
MiMedia Holdings Inc
F:KH3
|
US |
|
First National Financial Corp
TSX:FN
|
CA |
|
V
|
Vow ASA
OSE:VOW
|
NO |
Wall St Price Targets
DC4 Price Targets Summary
Dexcom Inc
According to Wall Street analysts, the average 1-year price target for DC4 is 76.06 EUR with a low forecast of 62.01 EUR and a high forecast of 100.27 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is DC4's stock price target?
Price Target
76.06
EUR
According to Wall Street analysts, the average 1-year price target for DC4 is 76.06 EUR with a low forecast of 62.01 EUR and a high forecast of 100.27 EUR.
What is the Revenue forecast for Dexcom Inc?
Projected CAGR
10%
Over the last 13 years, the compound annual growth rate for Revenue has been 34%. The projected CAGR for the next 8 years is 10%.
What is the Operating Income forecast for Dexcom Inc?
Projected CAGR
16%
The compound annual growth rate for Operating Income over the next 8 years is 16%.
What is the Net Income forecast for Dexcom Inc?
Projected CAGR
19%
The compound annual growth rate for Net Income over the next 5 years is 19%.
